Subscribe

Phoebe Starr

Authored Articles

Improving Diversity in Clinical Trials
Phoebe Starr
Disparities in Cancer Care, ASCO 2023 Highlights
August 2023, Vol 14, No 4
Read Article
Partnering With Patients Key to Improving Healthcare Outcomes
Phoebe Starr
ASCO 2023 Highlights
August 2023, Vol 14, No 4
Read Article
Ribociclib Plus Endocrine Therapy Improves Invasive Disease-Free Survival in Patients With HR-Positive, HER2-Negative, Early Breast Cancer
Phoebe Starr
ASCO 2023 Highlights, Breast Cancer
August 2023, Vol 14, No 4
Read Article
Final OS Analysis Confirms Benefit of Pembrolizumab Plus Chemotherapy With or Without Bevacizumab for First-Line Treatment of Cervical Cancer
Phoebe Starr
ASCO 2023 Highlights, Cervical Cancer, Gynecologic Cancer, Women's Health
August 2023, Vol 14, No 4
Read Article
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
ASCO 2023 Highlights, Myelodysplastic Syndromes, Hematologic Malignancies
August 2023, Vol 14, No 4
Read Article
Research Indicates Fewer People Understand the Link Between HPV and Certain Cancers
Phoebe Starr
Cancer Prevention, AACR 2023 Annual Meeting
June 2023, Vol 14, No 3 - Online Only
Read Article
Investigational mRNA-Based Vaccine May Offer New Hope for Patients With High-Risk Melanoma
Phoebe Starr
Emerging Therapies, Melanoma, Skin Cancer, AACR 2023 Annual Meeting
June 2023, Vol 14, No 3 - Online Only
Read Article
Pausing Endocrine Therapy to Become Pregnant Appears Safe for Women with Breast Cancer
Phoebe Starr
Women's Health, Breast Cancer
April 2023, Vol 14, No 2
Read Article
Zanubrutinib Superior to Ibrutinib in Patients with Relapsed or Refractory CLL/SLL
Phoebe Starr
ASH Highlights, Leukemia, Lymphoma
February 2023, Vol 14, No 1
Read Article
Ribociclib plus Endocrine Regimen Outperforms Combination Chemotherapy in Advanced Breast Cancer
Phoebe Starr
SABCS Highlights, Breast Cancer
February 2023, Vol 14, No 1
Read Article
Restrictive Diet May Not Be Necessary for Patients Undergoing HSCT
Phoebe Starr
ASH Highlights, Hematologic Malignancies
February 2023, Vol 14, No 1
Read Article
Adding Radiation to Systemic Therapy Improves Survival in Patients with Advanced Hepatocellular Cancer
Phoebe Starr
ASTRO Meeting Highlights, Hepatocellular Carcinoma
February 2023, Vol 14, No 1
Read Article
Shortened Course of Radiotherapy Feasible in Men with High-Risk Prostate Cancer
Phoebe Starr
Prostate Cancer, ASTRO Meeting Highlights
December 2022, Vol 13, No 6
Read Article
First-Line Brentuximab Vedotin plus Chemotherapy Improves OS in Advanced Hodgkin Lymphoma
Phoebe Starr
NCCN 2022 Hematologic Malignancies
December 2022, Vol 13, No 6
Read Article
Multicancer Early Detection Blood Test May Change Screening Paradigm
Phoebe Starr
Cancer Screening, ESMO
December 2022, Vol 13, No 6
Read Article
Female Patients Undergoing Cancer Treatment Rarely Asked About Sexual Health
Phoebe Starr
ASTRO Meeting Highlights
December 2022, Vol 13, No 6
Read Article
The Evolving Landscape for Diagnosing and Treating AML
Phoebe Starr
NCCN 2022 Hematologic Malignancies
December 2022, Vol 13, No 6
Read Article
Survey Reveals Physicians’ Attitudes Toward Biosimilars
Phoebe Starr
Biosimilars
December 2022, Vol 13, No 6
Read Article
Researchers Discover How Air Pollution May Trigger Lung Cancer in Never-Smokers
Phoebe Starr
ESMO 2022 Highlights
October 2022, Vol 13, No 5
Read Article
DETERMINATION Trial Confirms Importance of Individualizing Therapy for Newly Diagnosed Multiple Myeloma
Phoebe Starr
Hematologic Malignancies
October 2022, Vol 13, No 5
Read Article
Integrating Digital Health Technology into Cancer Care
Phoebe Starr
ESMO 2022 Highlights
October 2022, Vol 13, No 5
Read Article
Novel Approach to the Treatment of Desmoid Tumors Shows Great Promise
Phoebe Starr
ESMO 2022 Highlights
October 2022, Vol 13, No 5
Read Article
Sotorasib Elicits Durable Responses in Patients with Metastatic NSCLC and KRAS Mutation
Phoebe Starr
Lung Cancer
August 2022, Vol 13, No 4 Online Only
Read Article
First-Line Treatment with Dostarlimab Led to Remission in All Patients with Mismatch Repair-Deficient Rectal Cancer
Phoebe Starr
ASCO 2022 Highlights, Rectal Cancer
August 2022, Vol 13, No 4 Online Only
Read Article
Black Patients with Cancer and COVID-19 More Likely to Have Treatment Disruptions Than White Patients
Phoebe Starr
ASCO 2022 Highlights
August 2022, Vol 13, No 4 Online Only
Read Article
Second-Line Treatment with Sacituzumab plus Pembrolizumab Shows Promising Activity in Metastatic Urothelial Cancer
Phoebe Starr
Genitourinary Cancers
August 2022, Vol 13, No 4 Online Only
Read Article
Acalabrutinib Shows Promise in Patients with MZL
Phoebe Starr
ASCO 2022 Highlights
August 2022, Vol 13, No 4 Online Only
Read Article
Better Communication Between Oncologists and Primary Care Physicians Critical for Providing Effective Survivorship Care
Phoebe Starr
Survivorship Care
August 2022, Vol 13, No 4 Online Only
Read Article
Olaparib plus Abiraterone Combination Significantly Improves Radiographic PFS in Men with Metastatic Castration-Resistant Prostate Cancer
Phoebe Starr
Genitourinary Cancers
August 2022, Vol 13, No 4 Online Only
Read Article
Niraparib plus Abiraterone Combination Extends PFS in Men with CRPC and HRR Gene Mutations
Phoebe Starr
Prostate Cancer
August 2022, Vol 13, No 4 Online Only
Read Article
Neoadjuvant Chemoimmunotherapy May Be New Standard of Care for Patients with Resectable NSCLC
Phoebe Starr
AACR Meeting Highlights
June 2022, Vol 13, No 3
Read Article
Peptide-Based CoVac-1 Vaccine Shows Promise Against COVID-19 in Patients with Cancer
Phoebe Starr
AACR Meeting Highlights
June 2022, Vol 13, No 3
Read Article
Genetic Score Makes PSA Screening More Accurate
Phoebe Starr
Prostate Cancer
June 2022, Vol 13, No 3
Read Article
Updated Results from KEYNOTE-564 Trial Confirm Benefit of Adjuvant Pembrolizumab in Patients with Renal-Cell Carcinoma at High Risk for Recurrence
Phoebe Starr
Renal-Cell Carcinoma
June 2022, Vol 13, No 3
Read Article
Polatuzumab Vedotin plus R-CHP Improves Progression-Free Survival in Newly Diagnosed DLBCL
Phoebe Starr
ASH Highlights
April 2022, Vol 13, No 2
Read Article
Isatuximab plus RVd Combination Achieves High Rates of No MRD in Patients with Multiple Myeloma
Phoebe Starr
ASH Highlights
April 2022, Vol 13, No 2
Read Article
Time-Limited Venetoclax-Based Regimens Show Efficacy in Fit Patients with CLL
Phoebe Starr
ASH Highlights
April 2022, Vol 13, No 2
Read Article
Trastuzumab Deruxtecan Shows Survival Benefit in HER2-Positive Advanced Gastric Cancers
Phoebe Starr
ASCO GI 2022 Highlights
April 2022, Vol 13, No 2
Read Article
Updated Results from KEYNOTE-564 Trial Confirm Benefit of Adjuvant Pembrolizumab in Patients with Renal-Cell Carcinoma at High Risk for Recurrence
Phoebe Starr
ASCO GU 2022 Highlights
April 2022, Vol 13, No 2
Read Article
Elacestrant Yields Positive Outcomes in Patients with ER-Positive, HER2-Negative Advanced or Metastatic Breast Cancer
Phoebe Starr
Breast Cancer
April 2022, Vol 13, No 2
Read Article
Study Finds 1 in 6 Patients with Cancer Experience “Long-Haul” COVID-19
Phoebe Starr
COVID-19 & Cancer
April 2022, Vol 13, No 2
Read Article
Abiraterone plus Prednisone Added to ADT Boosts Survival in Patients with High-Risk Prostate Cancer
Phoebe Starr
Prostate Cancer
February 2022, Vol 13, No 1 Online Only
Read Article
Adagrasib Demonstrates Promising Activity in Patients with KRASᴳ¹²ᶜ-Mutated Metastatic Colorectal Cancer
Phoebe Starr
Colorectal Cancer
February 2022, Vol 13, No 1 Online Only
Read Article
Trastuzumab Deruxtecan Promising in Patients with HER2-Positive Breast Cancer and Brain Metastases
Phoebe Starr
SABCS Highlights
February 2022, Vol 13, No 1 Online Only
Read Article
KEYNOTE-355: Pembrolizumab plus Chemotherapy Extends Survival in Patients with Triple-Negative Breast Cancer and PD-L1 Combined Positive Score ≥10
Phoebe Starr
SABCS Highlights
February 2022, Vol 13, No 1 Online Only
Read Article
Lisaftoclax Demonstrates Preliminary Efficacy and Tolerability in Relapsed or Refractory CLL/SLL
Phoebe Starr
Hematologic Malignancies, Leukemia
October 2021, Vol 12, No 5
Read Article
Copanlisib plus Rituximab Prolongs Survival in Relapsed Indolent Non-Hodgkin Lymphoma
Phoebe Starr
Hematologic Malignancies
October 2021, Vol 12, No 5
Read Article
Sotorasib Shows Encouraging Activity in Patients with NSCLC and KRAS p.G12C Mutation
Phoebe Starr
Lung Cancer
October 2021, Vol 12, No 5
Read Article
Neoadjuvant Nivolumab plus Chemotherapy Significantly Improves Pathologic Complete Response in Patients with Resectable NSCLC
Phoebe Starr
Lung Cancer
October 2021, Vol 12, No 5
Read Article
Atezolizumab Extends Disease-Free Survival in PD-L1−Positive Early-Stage NSCLC
Phoebe Starr
ASCO 2021 Highlights, Lung Cancer
August 2021, Vol 12, No 4
Read Article
¹⁷⁷Lu-PSMA-617 Prolongs Survival in Patients with Metastatic Castration-Resistant Prostate Cancer
Phoebe Starr
ASCO 2021 Highlights, Prostate Cancer
August 2021, Vol 12, No 4
Read Article
Adjuvant Pembrolizumab Therapy Significantly Extends Disease-Free Survival in Patients with Clear-Cell Renal-Cell Carcinoma
Phoebe Starr
Renal-Cell Carcinoma
August 2021, Vol 12, No 4
Read Article
Tebentafusp Extends Survival in Patients with Metastatic Uveal Melanoma
Phoebe Starr
AACR Meeting Highlights
June 2021, Vol 12, No 3
Read Article
Current and Future Effects of the COVID-19 Pandemic on Cancer Care
Phoebe Starr
COVID-19
June 2021, Vol 12, No 3
Read Article
The Alliance for Innovation in Integrated Healthcare Provides New Forum for Stakeholders
Phoebe Starr
Value-Based Care
June 2021, Vol 12, No 3
Read Article
Selpercatinib Demonstrates Promising Activity in a Variety of RET Fusion–Positive Solid Tumor Types
Phoebe Starr
AACR Meeting Highlights
June 2021, Vol 12, No 3
Read Article
Adjuvant Chemotherapy May Be Beneficial in Premenopausal Women with HR-Positive, Early-Stage Breast Cancer
Phoebe Starr
Breast Cancer
June 2021, Vol 12, No 3
Read Article
Germline Variants Linked to High Heritability and Worse Outcomes in Pediatric Neuroblastoma
Phoebe Starr
Genetic Testing
June 2021, Vol 12, No 3
Read Article
Abemaciclib Added to Endocrine Therapy Reduces Invasive Disease Recurrence in High-Risk HR-Positive Early Breast Cancer: monarchE
Phoebe Starr
Breast Cancer
April 2021, Vol 12, No 2
Read Article
Enfortumab Vedotin Extends Survival in Metastatic Urothelial Cancer
Phoebe Starr
ASCO 2021 Highlights
April 2021, Vol 12, No 2
Read Article
Sacituzumab Govitecan Improves Progression-Free Survival in Metastatic Triple-Negative Breast Cancer with Brain Metastases
Phoebe Starr
Breast Cancer
April 2021, Vol 12, No 2
Read Article
First-Line Pembrolizumab plus Chemotherapy Extend Progression-Free Survival in Patients with Metastatic Triple-Negative Breast Cancer
Phoebe Starr
Breast Cancer
April 2021, Vol 12, No 2
Read Article
Belzutifan: Novel Approach to Advanced RCC
Phoebe Starr
ASCO 2021 Highlights
April 2021, Vol 12, No 2
Read Article
¹⁷⁷Lu-PSMA-617 Superior to Cabazitaxel in Metastatic Prostate Cancer
Phoebe Starr
ASCO 2021 Highlights
April 2021, Vol 12, No 2
Read Article
Nivolumab plus Cabozantinib Superior to Sunitinib as First-Line Treatment for RCC
Phoebe Starr
ASCO 2021 Highlights
April 2021, Vol 12, No 2
Read Article
Ruxolitinib in Graft-versus-Host Disease: Practice-Changing Results
Phoebe Starr
Graft-Versus-Host Disease
February 2021, Vol 12, No 1
Read Article
Asciminib, First-in-Class STAMP Inhibitor, Superior to Bosutinib in Chronic-Phase CML
Phoebe Starr
Leukemia
February 2021, Vol 12, No 1
Read Article
Novel Target: RARA Agonist plus Azacitidine Active in Relapsed or Refractory Acute Myeloid Leukemia
Phoebe Starr
Emerging Therapies
February 2021, Vol 12, No 1
Read Article
First-Line Fixed-Duration Ibrutinib plus Venetoclax Therapy Leads to Deep Remissions in Patients with Chronic Lymphocytic Leukemia
Phoebe Starr
Leukemia
February 2021, Vol 12, No 1
Read Article
Momelotinib, a Novel JAK Inhibitor, Makes Inroads in Intermediate- or High-Risk Myelofibrosis
Phoebe Starr
Myelofibrosis
February 2021, Vol 12, No 1
Read Article
Sotorasib, First-in-Class KRAS G12C Inhibitor, Hailed as “Triumph of Drug Discovery”
Phoebe Starr
Emerging Therapies
December 2020, Vol 11, No 6
Read Article
Xevinapant Improves Overall Survival in Patients with Head and Neck Squamous-Cell Carcinoma
Phoebe Starr
Emerging Therapies
December 2020, Vol 11, No 6
Read Article
CAR T-Cell Therapy May Not Be Needed in Select Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Phoebe Starr
NCCN 2020 Hematologic Malignancies
December 2020, Vol 11, No 6
Read Article
Aggressive Approach to High-Risk Smoldering Myeloma Gains Consensus
Phoebe Starr
NCCN 2020 Hematologic Malignancies
December 2020, Vol 11, No 6
Read Article
Explosion of Treatment Regimens for Multiple Myeloma: Selecting the Right Option for the Right Patient
Phoebe Starr
Multiple Myeloma, NCCN 2020 Hematologic Malignancies
December 2020, Vol 11, No 6
Read Article
First-Line Lorlatinib Shows “Astonishing Results” in Patients with ALK-Positive NSCLC
Phoebe Starr
Lung Cancer
December 2020, Vol 11, No 6
Read Article
Cemiplimab Improves Survival versus Chemotherapy in Patients with Advanced NSCLC and PD-L1 ≥50%
Phoebe Starr
Lung Cancer
December 2020, Vol 11, No 6
Read Article
COVID-Related Death Rate Tripled in Patients with Cancer versus the General Population
Phoebe Starr
AACR COVID-19 Highlights, COVID-19
October 2020, Vol 11, No 5
Read Article
Adjuvant Abemaciclib plus Endocrine Therapy Game-Changer in High-Risk, HR-Positive, HER2-Negative Early Breast Cancer
Phoebe Starr
ESMO 2020 Highlights
October 2020, Vol 11, No 5
Read Article
COVID-19 a Perpetual Challenge, Requiring Ongoing Vigilance
Phoebe Starr
AACR COVID-19 Highlights
October 2020, Vol 11, No 5
Read Article
Immune Checkpoint Inhibitors Have No Harmful Effect on Patients with Cancer and COVID-19
Phoebe Starr
AACR COVID-19 Highlights
October 2020, Vol 11, No 5
Read Article
Olaparib a New Option for Men with Metastatic Prostate Cancer and BRCA Mutation
Phoebe Starr
ESMO 2020 Highlights
October 2020, Vol 11, No 5
Read Article
Cabozantinib plus Nivolumab Combination Potential New First-Line Option for Patients with Advanced Renal-Cell Carcinoma
Phoebe Starr
ESMO 2020 Highlights
October 2020, Vol 11, No 5
Read Article
Nivolumab New Standard of Care in Gastroesophageal Cancers as First-Line or Adjuvant Therapy
Phoebe Starr
ESMO 2020 Highlights
October 2020, Vol 11, No 5
Read Article
Adjuvant Immunotherapy with Ipilimumab Improves Survival in Patients with Stage III Melanoma in the Real-World Setting
Phoebe Starr
Melanoma
October 2020, Vol 11, No 5
Read Article
Prevalence of Germline Mutations Surprisingly High in Young Adults with Early-Onset Cancer
Phoebe Starr
Biomarkers
October 2020, Vol 11, No 5
Read Article
Pembrolizumab New Standard of Care for Relapsed or Refractory Classical Hodgkin Lymphoma
Phoebe Starr
Lymphoma
October 2020, Vol 11, No 5
Read Article
Personalized Vaccine plus Immune Checkpoint Inhibitor a Promising Approach to Cancer
Phoebe Starr
Immunotherapy
October 2020, Vol 11, No 5
Read Article
Oral Relugolix Equals Standard ADT, Slashes Cardiac Events in Patients with Advanced Prostate Cancer
Phoebe Starr
Prostate Cancer
August 2020, Vol 11, Special Issue: Payers' Perspectives in Oncology
Read Article
Durvalumab plus Chemotherapy New Standard of Care for Extensive-Stage Small-Cell Lung Cancer
Phoebe Starr
Lung Cancer
August 2020, Vol 11, Special Issue: Payers' Perspectives in Oncology
Read Article
Cabozantinib plus Atezolizumab Combination Shows Meaningful Activity in Metastatic Prostate Cancer
Phoebe Starr
Prostate Cancer
August 2020, Vol 11, Special Issue: Payers' Perspectives in Oncology
Read Article
No Survival Benefit with Surgery and Radiation Added to Systemic Therapy in Patients with Newly Diagnosed Stage IV Breast Cancer
Phoebe Starr
Breast Cancer
August 2020, Vol 11, Special Issue: Payers' Perspectives in Oncology
Read Article
Maintenance Avelumab New Standard of Care for Advanced Bladder Cancer
Phoebe Starr
Bladder Cancer
August 2020, Vol 11, Special Issue: Payers' Perspectives in Oncology
Read Article
Early Phase 2 Data Promising for Lutetium-177 PSMA-617 in Metastatic Prostate Cancer
Phoebe Starr
Prostate Cancer
August 2020, Vol 11, Special Issue: Payers' Perspectives in Oncology
Read Article
Adjuvant Atezolizumab Did Not Show Disease-Free Survival Benefit in High-Risk Urothelial Cancer
Phoebe Starr
Bladder Cancer
August 2020, Vol 11, Special Issue: Payers' Perspectives in Oncology
Read Article
SBRT plus Immunotherapy in Metastatic Renal-Cell Carcinoma Warrants Further Study
Phoebe Starr
Renal-Cell Cancer
Web Exclusives
Read Article
Why Is COVID-19 More Aggressive in Certain Patients with Cancer?
Phoebe Starr
AACR Meeting Highlights, COVID-19
June 2020, Vol 11, No 3
Read Article
I-SPY 2: Durvalumab plus Olaparib and Paclitaxel Triplet in High-Risk Breast Cancer “Graduates” to Phase 3 Study
Phoebe Starr
Breast Cancer
June 2020, Vol 11, No 3
Read Article
Atezolizumab, Vemurafenib, and Cobimetinib Triplet Therapy Improves PFS in BRAF-Positive Melanoma
Phoebe Starr
AACR Meeting Highlights
June 2020, Vol 11, No 3
Read Article
ctDNA Potential Biomarker for MRD Positivity and Relapse After Surgery in Patients with NSCLC
Phoebe Starr
AACR Meeting Highlights
June 2020, Vol 11, No 3
Read Article
Capecitabine Improves Outcomes in TNBC When Added to Other Systemic Therapy
Phoebe Starr
Breast Cancer
June 2020, Vol 11, No 3
Read Article
Immune Checkpoint Inhibitor Does Not Improve Outcomes in Metastatic Prostate Cancer
Phoebe Starr
Prostate Cancer
June 2020, Vol 11, No 3
Read Article
Sitravatinib, Novel TKI, plus Nivolumab Elicits Good Responses in Renal-Cell Carcinoma
Phoebe Starr
Renal-Cell Cancer
June 2020, Vol 11, No 3
Read Article
First-in-Class Oral MK-6482 Shows Exciting Results in Clear-Cell Renal-Cell Carcinoma
Phoebe Starr
Renal-Cell Cancer
June 2020, Vol 11, No 3
Read Article
PSMA-PET Scanning Wave of the Future in Prostate Cancer
Phoebe Starr
Prostate Cancer
April 2020, Vol 11, No 2
Read Article
Tucatinib Fills Unmet Need in Heavily Pretreated HER2-Positive Metastatic Breast Cancer, Including Brain Metastasis
Phoebe Starr
Breast Cancer
April 2020, Vol 11, No 2
Read Article
“Unheard of” Results with Trastuzumab Deruxtecan in Metastatic HER2-Positive Breast Cancer
Phoebe Starr
Breast Cancer
April 2020, Vol 11, No 2
Read Article
Novel BCMA-Directed CAR T-Cell Therapy Had Excellent Responses in Heavily Pretreated Patients with Multiple Myeloma
Phoebe Starr
Hematologic Malignancies, Multiple Myeloma, Personalized Medicine
February 2020, Vol 11, No 1 | Payers’ Perspectives In Oncology | Including ASH 2019 Highlights
Read Article
Zanubrutinib, Next-Generation BTK, Leads to Impressive Responses in Patients with CLL or SLL
Phoebe Starr
Leukemia, Personalized Medicine
February 2020, Vol 11, No 1 | Payers’ Perspectives In Oncology | Including ASH 2019 Highlights
Read Article
Mosunetuzumab, a Dual-Targeted Antibody, Shows Complete Remissions in Relapsed/Refractory NHL After CAR T-Cell Therapy
Phoebe Starr
Emerging Therapies
February 2020, Vol 11, No 1 | Payers’ Perspectives In Oncology | Including ASH 2019 Highlights
Read Article
Dual-Targeted CAR T-Cell Therapy Leads to Very High Response Rates in Relapsed or Refractory Multiple Myeloma
Phoebe Starr
Hematologic Malignancies, Multiple Myeloma, Personalized Medicine
February 2020, Vol 11, No 1 | Payers’ Perspectives In Oncology | Including ASH 2019 Highlights
Read Article
Real-World Healthcare Utilization and Costs Support Broader Use of CAR T-Cell Therapy
Phoebe Starr
Economics & Value, Value-Based Care
February 2020, Vol 11, No 1 | Payers’ Perspectives In Oncology | Including ASH 2019 Highlights
Read Article
Osimertinib Superior TKI as First-Line Treatment of Advanced NSCLC with EGFR Mutation
Phoebe Starr
Lung Cancer, Personalized Medicine, Solid Tumors
December 2019, Vol 10, No 6
Read Article
Targeted Therapy with Olaparib Beneficial in Metastatic Prostate Cancer with Gene Mutations
Phoebe Starr
ESMO 2019
December 2019, Vol 10, No 6
Read Article
Ceritinib Effective in Treating Brain Metastases in NSCLC
Phoebe Starr
ESMO 2019
December 2019, Vol 10, No 6
Read Article
Paradigm Shift: PARP Inhibitors Should Be Offered to All Patients with Ovarian Cancer
Phoebe Starr
ESMO 2019
December 2019, Vol 10, No 6
Read Article
With Access to Care, Black Men in the United States Have Same Prostate Cancer Outcomes as White Men
Phoebe Starr
Prostate Cancer, Solid Tumors, Personalized Medicine
August 2018, Vol 9, No 2 | Payers’ Perspectives In Oncology: ASCO
Read Article
Long-Term Data Confirm Survival Benefit for Pembrolizumab in Advanced NSCLC
Phoebe Starr
Lung Cancer, Solid Tumors, Personalized Medicine
October 2019, Vol 10, No 5
Read Article
Adding CDK4/6 Inhibitor to Endocrine Therapy Improves Survival in Advanced Breast Cancer: New Standard of Care
Phoebe Starr
ESMO 2019
October 2019, Vol 10, No 5
Read Article
Enfortumab Vedotin Promising Third-Line Option for Metastatic Urothelial Cancer
Phoebe Starr
Emerging Therapies, Personalized Medicine
August 2019, Vol 10, No 4 | Payers’ Perspectives In Oncology: ASCO
Read Article
Fixed-Duration Targeted Therapy with Venetoclax plus Obinutuzumab New Front-Line Standard for Patients with Chronic Lymphocytic Leukemia
Phoebe Starr
Hematologic Malignancies, Leukemia, Personalized Medicine
August 2019, Vol 10, No 4 | Payers’ Perspectives In Oncology: ASCO
Read Article
MONALEESA-7 Sets New Standard of Care for Premenopausal Advanced Breast Cancer: Adding CDK4/6 to Endocrine Therapy Extends Survival
Phoebe Starr
Breast Cancer, Personalized Medicine, Solid Tumors
August 2019, Vol 10, No 4 | Payers’ Perspectives In Oncology: ASCO
Read Article
Practice-Changing Results: Olaparib Maintenance Therapy Extends Progression-Free Survival in Metastatic Pancreatic Cancer with Germline BRCA Mutation
Phoebe Starr
Pancreatic Cancer, Personalized Medicine
August 2019, Vol 10, No 4 | Payers’ Perspectives In Oncology: ASCO
Read Article
FDA Unveils Oncology-Specific “Project Facilitate,” Expanding Access to Investigational Cancer Drugs
Phoebe Starr
Economics & Value, Value-Based Care
August 2019, Vol 10, No 4 | Payers’ Perspectives In Oncology: ASCO
Read Article
Alpelisib Prolongs Progression-Free Survival in Advanced Breast Cancer with PIK3CA Mutation
Phoebe Starr
Breast Cancer, In the Literature
August 2019, Vol 10, No 4 | Payers’ Perspectives In Oncology: ASCO
Read Article
Osimertinib plus Savolitinib Promising for Advanced Non–Small-Cell Lung Cancer and MET-Driven Resistance
Phoebe Starr
Lung Cancer, Solid Tumors, Personalized Medicine
June 2019, Vol 10, No 3
Read Article
T-DM1 Reduces Residual Invasive Disease in Patients with HER2-Positive Breast Cancer After Chemotherapy
Phoebe Starr
Breast Cancer
June 2019, Vol 10, No 3
Read Article
First Positive Showing for Mesothelin-Directed CAR T-Cell Therapy in Solid Tumors
Phoebe Starr
Immunotherapy, Personalized Medicine
June 2019, Vol 10, No 3
Read Article
Infigratinib a Novel, Potent Selective TKI Targeting FGFR Fusions in Different Tumor Types
Phoebe Starr
June 2019, Vol 10, No 3
Read Article
Umbralisib Shows Encouraging Results in Relapsed or Refractory Marginal-Zone Lymphoma
Phoebe Starr
Emerging Therapies, Personalized Medicine
June 2019, Vol 10, No 3
Read Article
Gilteritinib a New Standard of Care for Relapsed or Refractory AML with FLT3 Mutation
Phoebe Starr
Leukemia, Hematologic Malignancies
June 2019, Vol 10, No 3
Read Article
Paradigm Shift: Ibrutinib plus Rituximab Front-Line Therapy for Patients Age 70 or Younger with CLL
Phoebe Starr
Leukemia, Hematologic Malignancies
June 2019, Vol 10, No 3
Read Article
CAR T-Cell Therapy Augments Response to Ibrutinib in Chronic Lymphocytic Leukemia
Phoebe Starr
Leukemia, Hematologic Malignancies
June 2019, Vol 10, No 3
Read Article
High Tumor Mutation Burden Predictive Biomarker for Survival in Metastatic Lung Cancer
Phoebe Starr
Lung Cancer, Solid Tumors, Personalized Medicine
June 2019, Vol 10, No 3
Read Article
Adjuvant Chemotherapy May Be Spared in Localized Breast Cancer If pCR Is Attained with Neoadjuvant Chemotherapy
Phoebe Starr
Breast Cancer
April 2019, Vol 10, No 2
Read Article
Tamoxifen 5 mg Daily as Effective as 20 mg in Early Localized Breast Cancer
Phoebe Starr
Breast Cancer
April 2019, Vol 10, No 2
Read Article
First-Line Pembrolizumab plus Axitinib Combination Boosts Survival in Metastatic Renal-Cell Carcinoma
Phoebe Starr
Genitourinary Cancers Symposium
April 2019, Vol 10, No 2
Read Article
Darolutamide, New Androgen Receptor Inhibitor, Extends Metastasis-Free Survival in High-Risk Prostate Cancer
Phoebe Starr
Prostate Cancer
April 2019, Vol 10, No 2
Read Article
Atezolizumab plus Nab-Paclitaxel for Triple-Negative Breast Cancer with PD-L1 Expression
Phoebe Starr
Breast Cancer
April 2019, Vol 10, No 2
Read Article
Explosive Development of BCMA CAR T-Cell Therapy for Multiple Myeloma
Phoebe Starr
Immunotherapy, Multiple Myeloma, Hematologic Malignancies, Personalized Medicine
Web Exclusives
Read Article
MURANO: Venetoclax-Rituximab at Fixed Duration Beats Chemo­immunotherapy in Relapsed/Refractory CLL
Phoebe Starr
Leukemia, Hematologic Malignancies
January/February 2019, Vol 10, No 1 | Payers’ Perspectives In Oncology: ASH 2018 Highlights
Read Article
Checkpoint Inhibitor a New Approach to Jump-Start a Waning Response to CAR T-Cell Therapy
Phoebe Starr
Immunotherapy, Personalized Medicine
January/February 2019, Vol 10, No 1 | Payers’ Perspectives In Oncology: ASH 2018 Highlights
Read Article
Durable Responses to CAR T-Cell Therapy in B-Cell Lymphomas
Phoebe Starr
Immunotherapy, Personalized Medicine
January/February 2019, Vol 10, No 1 | Payers’ Perspectives In Oncology: ASH 2018 Highlights
Read Article
Researchers Identify First Mutation to Explain Resistance to Venetoclax
Phoebe Starr
Leukemia, Hematologic Malignancies
January/February 2019, Vol 10, No 1 | Payers’ Perspectives In Oncology: ASH 2018 Highlights
Read Article
Explosive Development of BCMA CAR T-Cell Therapies for Multiple Myeloma
Phoebe Starr
Immunotherapy, Multiple Myeloma, Hematologic Malignancies, Personalized Medicine
January/February 2019, Vol 10, No 1 | Payers’ Perspectives In Oncology: ASH 2018 Highlights
Read Article
Nelarabine Therapy Up Front Boosts Survival in T-Cell Leukemia and Lymphoma
Phoebe Starr
Hematologic Malignancies, Leukemia
August 2018, Vol 9, No 2 | Payers’ Perspectives In Oncology: ASCO
Read Article
Cost of Treating Colorectal Cancer in the United States Double That of Canada, with No Survival Benefitc
Phoebe Starr
Economics & Value, Value-Based Care
August 2018, Vol 9, No 2 | Payers’ Perspectives In Oncology: ASCO
Read Article
Next-Generation Sequencing More Cost-Effective and Faster Than Single-Gene Testing
Phoebe Starr
Economics & Value, Value-Based Care
August 2018, Vol 9, No 2 | Payers’ Perspectives In Oncology: ASCO
Read Article
Ivosidenib a New Standard of Care for Relapsed or Refractory AML with IDH1 Mutation
Phoebe Starr
Emerging Therapies, Personalized Medicine
August 2018, Vol 9, No 2 | Payers’ Perspectives In Oncology: ASCO
Read Article
Immunotherapy Combinations “Raising the Bar”
Phoebe Starr
Immunotherapy, Personalized Medicine
August 2018, Vol 9, No 2 | Payers’ Perspectives In Oncology: ASCO
Read Article
Less Is More: Six Months of Trastuzumab Equivalent to 12 months in HER2-Positive Breast Cancer
Phoebe Starr
Breast Cancer
August 2018, Vol 9, No 2 | Payers’ Perspectives In Oncology: ASCO
Read Article
Chemotherapy Can Be Spared in Many Patients with Early Breast Cancer: Devil Is in the Details
Phoebe Starr
Breast Cancer, Chemotherapy, Personalized Medicine
August 2018, Vol 9, No 2 | Payers’ Perspectives In Oncology: ASCO
Read Article
CAR T-Cell Manufacturing Process Depends on Good Quality T-Cells
Phoebe Starr
Immunotherapy, Personalized Medicine
Web Exclusives
Read Article
PET-Directed Approach Can Guide Radiation Therapy in Diffuse Large B-Cell Lymphoma
Phoebe Starr
Lymphoma, Solid Tumors, Personalized Medicine
February 2018, Vol 9, No 1 | Payers' Perspectives In Oncology: ASH 2017 Highlights
Read Article
A New Combination as First-Line Regimen in Advanced Hodgkin Lymphoma?
Phoebe Starr
Lymphoma
February 2018, Vol 9, No 1 | Payers' Perspectives In Oncology: ASH 2017 Highlights
Read Article
Venetoclax plus Rituximab New Chemotherapy-Free Option for Chronic Lymphocytic Leukemia
Phoebe Starr
Leukemia, Hematologic Malignancies
February 2018, Vol 9, No 1 | Payers' Perspectives In Oncology: ASH 2017 Highlights
Read Article
CAR T-Cell Therapy Makes Significant Inroads in Lymphoma: Kymriah and Yescarta Show Durable Remissions
Phoebe Starr
Immunotherapy, Personalized Medicine
February 2018, Vol 9, No 1 | Payers' Perspectives In Oncology: ASH 2017 Highlights
Read Article
Taselisib, a PI3K Inhibitor, Shrinks Tumors in Early Breast Cancer, with Added Activity in Patients with PI3KCA Mutation
Phoebe Starr
ESMO 2017 Highlights, ESMO
December 2017, Vol 8, No 5
Read Article
Rucaparib Maintenance Extends Survival
Phoebe Starr
ESMO 2017 Highlights, ESMO
December 2017, Vol 8, No 5
Read Article
Potentially Practice-Changing Results: PD-L1 Inhibitor for Unresectable, Stage III Lung Cancer
Phoebe Starr
ESMO 2017 Highlights, ESMO
December 2017, Vol 8, No 5
Read Article
Less Is More: Low-Risk Stage III Colon Cancer Safely Treated with Only 3 Months of Adjuvant Chemotherapy
Phoebe Starr
Colon Cancer
August 2017, Vol 8, No 4 | Payers' Perspectives In Oncology: ASCO 2017 Highlights
Read Article
Abemaciclib, a New CDK4/CDK6 Inhibitor, Added to Fulvestrant Extends PFS in Advanced HR-Positive, HER2-Negative Breast Cancer
Phoebe Starr
Breast Cancer, Solid Tumors, Personalized Medicine
August 2017, Vol 8, No 4 | Payers' Perspectives In Oncology: ASCO 2017 Highlights
Read Article
Alectinib New Standard of Care for ALK-Positive Non–Small-Cell Lung Cancer
Phoebe Starr
Lung Cancer, Solid Tumors, Personalized Medicine
August 2017, Vol 8, No 4 | Payers' Perspectives In Oncology: ASCO 2017 Highlights
Read Article
Proactive Symptom Self-Reporting Extends Survival in Patients with Metastatic Cancer
Phoebe Starr
Economics & Value, Value-Based Care
August 2017, Vol 8, No 4 | Payers' Perspectives In Oncology: ASCO 2017 Highlights
Read Article
Checkpoint Inhibitors Show Promise in Patients with Mesothelioma
Phoebe Starr
Immunotherapy, Personalized Medicine, Mesothelioma
August 2017, Vol 8, No 4 | Payers' Perspectives In Oncology: ASCO 2017 Highlights
Read Article
Pembrolizumab Makes Inroads in Sarcoma Subtypes
Phoebe Starr
Immunotherapy, Personalized Medicine
August 2017, Vol 8, No 4 | Payers' Perspectives In Oncology: ASCO 2017 Highlights
Read Article
Novel Assay Provides 100 Times More Information Than Current Liquid Biopsies for Early Cancer Detection
Phoebe Starr
Emerging Therapies, Personalized Medicine
August 2017, Vol 8, No 4 | Payers' Perspectives In Oncology: ASCO 2017 Highlights
Read Article
Novel Drug “Home Run” for TRK Mutation–Positive Tumors
Phoebe Starr
Emerging Therapies, Personalized Medicine
August 2017, Vol 8, No 4 | Payers' Perspectives In Oncology: ASCO 2017 Highlights
Read Article
Longest Follow-Up in Patients with NSCLC Who Responded to Immunotherapy with Nivolumab
Phoebe Starr
Immunotherapy, Personalized Medicine
June 2017, Vol 8, No 3
Read Article
Excellent Responses to Atezolizumab in Small Subset of Women with Triple-Negative Breast Cancer
Phoebe Starr
Breast Cancer, Solid Tumors, Personalized Medicine
June 2017, Vol 8, No 3
Read Article
Adding Indoximod to Pembrolizumab Boosts Immune Response in Melanoma
Phoebe Starr
Immunotherapy, Personalized Medicine
June 2017, Vol 8, No 3
Read Article
Atezolizumab plus Bevacizumab Combo Shows Promise in Patients with Metastatic Kidney Cancer
Phoebe Starr
Immunotherapy, Personalized Medicine
June 2017, Vol 8, No 3
Read Article
Optimizing Treatment for Non–Muscle Invasive Bladder Cancer
Phoebe Starr
Genitourinary Cancers Symposium, Genitourinary Cancers
April 2017, Vol 8, No 2
Read Article
Real-World Outcomes Show Benefits of Immune Checkpoint Inhibitors in Patients with Kidney Cancer
Phoebe Starr
Genitourinary Cancers Symposium, Genitourinary Cancers
April 2017, Vol 8, No 2
Read Article
1 Cycle of BEP Regimen Equal to 2 Cycles in Patients with High-Risk, Stage 1 Testicular Cancer
Phoebe Starr
Genitourinary Cancers Symposium, Genitourinary Cancers
April 2017, Vol 8, No 2
Read Article
Benefit of Extended Adjuvant Aromatase Inhibition in Breast Cancer Now in Question
Phoebe Starr
Breast Cancer, Solid Tumors, Personalized Medicine
April 2017, Vol 8, No 2
Read Article
Good News for a Different Type of CDK4/CDK6 Inhibitor in Early Breast Cancer
Phoebe Starr
Breast Cancer, Solid Tumors, Personalized Medicine
April 2017, Vol 8, No 2
Read Article
Strategies to Reduce the Use of Tyrosine Kinase Inhibitors in CML
Phoebe Starr
Leukemia
February 2017, Vol 8, No 1
Read Article
CPX-351 Improves Posttransplant Survival in Older Patients with High-Risk Acute Myeloid Leukemia
Phoebe Starr
Leukemia
February 2017, Vol 8, No 1
Read Article
Pacritinib Shows Good Efficacy in Myelofibrosis: Will the FDA Release Hold on the Drug?
Phoebe Starr
Myelofibrosis
February 2017, Vol 8, No 1
Read Article
Adjuvant Sunitinib Therapy Improves Outcomes in Clear-Cell Renal-Cell Carcinoma
Phoebe Starr
Renal-Cell Carcinoma
November 2016, Vol 7, No 10
Read Article
Pembrolizumab Succeeds, Nivolumab Fails, as First-Line Therapy for Advanced NSCLC
Phoebe Starr
Lung Cancer, Solid Tumors
November 2016, Vol 7, No 10
Read Article
Nivolumab Improves Quality of Life versus Chemotherapy in Patients with Head and Neck Cancer
Phoebe Starr
November 2016, Vol 7, No 10
Read Article
Niraparib Extends Progression-Free Survival in Platinum-Sensitive Ovarian Cancer
Phoebe Starr
Ovarian Cancer
November 2016, Vol 7, No 10
Read Article
Ribociclib-Letrozole Combination Potentially Practice-Changing in Advanced Breast Cancer
Phoebe Starr
ESMO 2016, ESMO
November 2016, Vol 7, No 10
Read Article
Molecular Subtypes Predict Response to Radiation in Prostate Cancer
Phoebe Starr
ASTRO Meeting Highlights
October 2016, Vol 7, No 9
Read Article
Hypofractionated Radiation May Be New Treatment Paradigm in Patients Unable to Receive Standard of Care
Phoebe Starr
ASTRO Annual Meeting
October 2016, Vol 7, No 9
Read Article
Radiation Boost Improves Local Control, Spares Salvage Mastectomy in Patients with Ductal Carcinoma in Situ
Phoebe Starr
ASTRO Meeting Highlights
October 2016, Vol 7, No 9
Read Article
Survival Increased with Value-Added Stereotactic Body Radiation Therapy in Patients with Lung Cancer
Phoebe Starr
ASTRO Meeting Highlights
October 2016, Vol 7, No 9
Read Article
Older Drugs in “New Clothes” Achieve Superior Outcomes
Phoebe Starr
Hematologic Malignancies, Leukemia, Personalized Medicine
October 2016, Vol 7, No 9
Read Article
Shorter Hypofractionated Therapy New Standard for Prostate Cancer
Phoebe Starr
Prostate Cancer, Solid Tumors
August 2016, Vol 7, No 7, Special Issue: Payers’ Perspectives in Oncology
Read Article
Combination Immunotherapy Makes Progress in Advanced Melanoma
Phoebe Starr
Melanoma
August 2016, Vol 7, No 7, Special Issue: Payers’ Perspectives in Oncology
Read Article
Refining the Use of CAR T-Cells in Patients with Acute Lymphoblastic Leukemia
Phoebe Starr
Hematologic Malignancies, Leukemia
August 2016, Vol 7, No 7, Special Issue: Payers’ Perspectives in Oncology
Read Article
Extending Letrozole Therapy Beyond 5 Years in Early Breast Cancer Reduces Recurrence
Phoebe Starr
Breast Cancer, Solid Tumors
August 2016, Vol 7, No 7, Special Issue: Payers’ Perspectives in Oncology
Read Article
A New Paradigm Matching Targeted Therapy to Molecular Alterations Independent of Tumor Type
Phoebe Starr
Personalized Medicine, Targeted Therapy
August 2016, Vol 7, No 7, Special Issue: Payers’ Perspectives in Oncology
Read Article
Aggressive End-of-Life Care Continues to Be Offered to Younger Patients with Cancer
Phoebe Starr
End-of-Life Care, Value in Oncology, Policies & Guidelines
August 2016, Vol 7, No 7, Special Issue: Payers’ Perspectives in Oncology
Read Article
“Smart Bomb” First-in-Class Drug Rova-T Promising Novel Therapy for Small-Cell Lung Cancer
Phoebe Starr
Emerging Therapies, Personalized Medicine
August 2016, Vol 7, No 7, Special Issue: Payers’ Perspectives in Oncology
Read Article
Adjuvant Chemoradiotherapy May Provide Benefit in Locally Advanced Bladder Cancer
Phoebe Starr
Genitourinary Cancers
July 2016, Vol 7, No 6
Read Article
Cost of Drugs and Affordability Don’t Always Jibe
Phoebe Starr
Value in Oncology
July 2016, Vol 7, No 6
Read Article
Real-World Data Show 2-Year Survival Predicts Long-Term Survival for Metastatic Germ-Cell Testicular Cancer
Phoebe Starr
Genitourinary Cancers
June 2016, Vol 7, No 5
Read Article
Early Results of Immunotherapy in Breast Cancer
Phoebe Starr
Breast Cancer, Solid Tumors
June 2016, Vol 7, No 5
Read Article
ESR1 Mutations Predict Worse Survival in ER-Positive Advanced Breast Cancer
Phoebe Starr
Personalized Medicine
June 2016, Vol 7, No 5
Read Article
Self-Reports of 6-Mercaptopurine Intake in Childhood Acute Lymphoblastic Leukemia Unreliable
Phoebe Starr
Hematologic Malignancies
May 2016, Vol 7, No 4
Read Article
Additional Chemotherapy Improves Survival in Women with Residual Disease After Neoadjuvant Chemotherapy
Phoebe Starr
Breast Cancer
May 2016, Vol 7, No 4
Read Article
Omit Chemotherapy for Luminal A Breast Cancer?
Phoebe Starr
Breast Cancer
May 2016, Vol 7, No 4
Read Article
Cabozantinib Improves on Standard of Care for Second-Line Treatment of Patients with Advanced Renal-Cell Carcinoma
Phoebe Starr
Genitourinary Cancers
May 2016, Vol 7, No 4
Read Article
Tamoxifen or Anastrozole for DCIS? Age and Symptoms Matter
Phoebe Starr
Breast Cancer, Solid Tumors
April 2016, Vol 7, No 3
Read Article
Survival Benefit for T-DM1 Confirmed in Metastatic Breast Cancer
Phoebe Starr
Breast Cancer, Solid Tumors
April 2016, Vol 7, No 3
Read Article
Reirradiation of Pelvic Area Safe, Improves Quality of Life
Phoebe Starr
Genitourinary Cancers
April 2016, Vol 7, No 3
Read Article
Another Study Shows Benefit of Pediatric Regimen in Young Adults with Acute Lymphoblastic Leukemia
Phoebe Starr
Hematologic Malignancies
April 2016, Vol 7, No 3
Read Article
Biomarker for Uveal Melanoma Has Immediate Clinical Impact
Phoebe Starr
Personalized Medicine
April 2016, Vol 7, No 3
Read Article
Genomics May Explain Poor Survival of African Americans with Kidney Cancer
Phoebe Starr
Personalized Medicine
April 2016, Vol 7, No 3
Read Article
Venetoclax Shows Strong Activity in CLL
Phoebe Starr
Emerging Therapies, Personalized Medicine
February 2016, Vol 7, No 1
Read Article
Checkpoint Inhibitors in Lymphoma: A New Universe
Phoebe Starr
Hematologic Malignancies, Immunotherapy, Lymphoma, Personalized Medicine
February 2016, Vol 7, No 1
Read Article
Ibrutinib a New Standard of Care for Elderly Patients with Chronic Lymphocytic Leukemia
Phoebe Starr
Hematologic Malignancies, Leukemia
February 2016, Vol 7, No 1
Read Article
Idelalisib Improves Survival When Added to Bendamustine plus Rituximab in Patients with CLL
Phoebe Starr
Hematologic Malignancies, Leukemia
February 2016, Vol 7, No 1
Read Article
The Hematologic Drug Pipeline: Exciting New Treatment Options Looming
Phoebe Starr
Emerging Therapies, Personalized Medicine
February 2016, Vol 7, No 1
Read Article
Midostaurin the First Targeted Therapy to Improve Survival in AML: Potentially Practice-Changing
Phoebe Starr
Emerging Therapies, Personalized Medicine
February 2016, Vol 7, No 1
Read Article
Regular Aspirin Use Reduces the Risk for Prostate Cancer Death
Phoebe Starr
Prostate Cancer, Solid Tumors
March 2016, Vol 7, No 2
Read Article
Myeloablative Conditioning Remains Standard of Care in Patients with Myelodysplastic Sydrome
Phoebe Starr
Hematologic Malignancies, Myelodysplastic Syndromes
March 2016, Vol 7, No 2
Read Article
Inotuzumab Ozogamicin Shows Promise in Older Patients with Acute Lymphoblastic Leukemia
Phoebe Starr
Emerging Therapies, Personalized Medicine
March 2016, Vol 7, No 2
Read Article
Liquid Biopsy Characterizing Circulating Tumor Cells Can Aid Treatment Selection in Prostate Cancer
Phoebe Starr
Personalized Medicine, Prostate Cancer, Solid Tumors
March 2016, Vol 7, No 2
Read Article
Teamwork Improves End-of-Life Care, Saves Money
Phoebe Starr
End-of-Life Care, Palliative Care, Policies & Guidelines, Personalized Medicine
December 2015, Vol 6, No 11
Read Article
Genomic Test Supports Treatment Decisions in Prostate Cancer
Phoebe Starr
Personalized Medicine, Prostate Cancer, Solid Tumors
December 2015, Vol 6, No 11
Read Article
Patients with Early Breast Cancer and Low Oncotype DX Scores Can Skip Chemotherapy
Phoebe Starr
Breast Cancer, Solid Tumors
October 2015, Vol 6, No 9
Read Article
Men’s Health Supplements Have No Value for Patients with Prostate Cancer
Phoebe Starr
Prostate Cancer, Solid Tumors
November 2015, Vol 6, No 10
Read Article
Chemotherapy Safe During Pregnancy in Second and Third Trimesters
Phoebe Starr
Chemotherapy, Pregnancy & Cancer, Personalized Medicine
November 2015, Vol 6, No 10
Read Article
Significant Benefits Seen with 2 New Options for Patients with Renal-Cell Carcinoma
Phoebe Starr
Emerging Therapies, Personalized Medicine
November 2015, Vol 6, No 10
Read Article
Everolimus, 177Lu-DOTATATE Potentially 2 Practice-Changing Options in NETs
Phoebe Starr
Emerging Therapies, Personalized Medicine
November 2015, Vol 6, No 10
Read Article
Atezolizumab: Another Immunotherapy for Lung Cancer?
Phoebe Starr
Emerging Therapies, Immunotherapy, Personalized Medicine
October 2015, Vol 6, No 9
Read Article
Combination of PARP and PI3K Inhibitors Share a Genomic Landscape in Breast and Ovarian Cancers
Phoebe Starr
Personalized Medicine
August 2015, Vol 6, No 7
Read Article
GADOLIN Trial: Obinutuzumab an Effective Treatment for Indolent Lymphoma
Phoebe Starr
Emerging Therapies, Personalized Medicine
August 2015, Vol 6, No 7
Read Article
Value-Based Strategies for Patients with Multiple Myeloma
Phoebe Starr
Hematologic Malignancies, Multiple Myeloma, Value-Based Care
August 2015, Vol 6, No 7
Read Article
Genetic Abnormality Pinpointed for Intensive Therapy in Wilms Tumor
Phoebe Starr
ASCO 2015 Highlights, ASCO
July 2015, Vol 6, No 6
Read Article
Elotuzumab, First-in-Class Monoclonal Antibody Immuno­­therapy, Improves Outcomes in Patients with Multiple Myeloma
Phoebe Starr
ASCO 2015 Highlights, ASCO
June 2015, Vol 6, No 5
Read Article
Genomic Sequencing for Pancreatic Cancer Still Facing Hurdles
Phoebe Starr
Personalized Medicine
June 2015, Vol 6, No 5
Read Article
Adding Ibrutinib to Standard Therapy Reduces Disease Progression by 80% in Previously Treated Patients with CLL
Phoebe Starr
Palliative Care, Personalized Medicine
June 2015, Vol 6, No 5
Read Article
Docetaxel Boosts Survival in Patients with Hormone-Naïve Metastatic Prostate Cancer
Phoebe Starr
ASCO 2015 Highlights, ASCO
June 2015, Vol 6, No 5
Read Article
Oral Nicotinamide Prevents Common Skin Cancers in High-Risk Patients
Phoebe Starr
ASCO 2015 Highlights, ASCO
June 2015, Vol 6, No 5
Read Article
Encouraging Results for Pembrolizumab in Head and Neck Cancer
Phoebe Starr
ASCO 2015 Highlights, ASCO
June 2015, Vol 6, No 5
Read Article
New Hope for Patients with Advanced Lung Cancer?
Phoebe Starr
AACR Meeting Highlights
May 2015, Vol 6, No 4
Read Article
Projections for 2030: Increase in ER-Positive, Decrease in ER-Negative Breast Cancer
Phoebe Starr
AACR Meeting Highlights
May 2015, Vol 6, No 4
Read Article
Liquid Biopsy Detects KRAS Mutations in Plasma DNA in Nonresectable Pancreatic Cancer, Can Predict Patient Outcomes
Phoebe Starr
AACR Meeting Highlights
May 2015, Vol 6, No 4
Read Article
Two Immunotherapies Are Better Than One in Advanced Melanoma
Phoebe Starr
AACR Meeting Highlights
May 2015, Vol 6, No 4
Read Article
Pembrolizumab Scores Big Over Ipilimumab in Advanced Melanoma
Phoebe Starr
AACR Meeting Highlights
May 2015, Vol 6, No 4
Read Article
Localized Renal Cancer Surgery Associated with Substantial Costs from Lost Productivity
Phoebe Starr
Genitourinary Cancers Symposium
March 2015, Vol 6, No 2
Read Article
Debate on PSA Prostate Cancer Screening Redux
Phoebe Starr
Genitourinary Cancers Symposium, Prostate Cancer, Solid Tumors
March 2015, Vol 6, No 2
Read Article
History of Testicular Cancer Increases Risk for Aggressive Prostate Cancer Later on
Phoebe Starr
Genitourinary Cancers Symposium
March 2015, Vol 6, No 2
Read Article
Caution: Active Surveillance Ill Advised in Men with Intermediate-Risk Prostate Cancer
Phoebe Starr
Genitourinary Cancers Symposium
March 2015, Vol 6, No 2
Read Article
AR-V7 Predicts Chemotherapy Sensitivity in Metastatic Prostate Cancer
Phoebe Starr
Personalized Medicine, Prostate Cancer, Solid Tumors
March 2015, Vol 6, No 2
Read Article
ASSURE Trial: No Role for Adjuvant Sorafenib or Sunitinib in Locally Advanced Kidney Cancer
Phoebe Starr
Genitourinary Cancers Symposium
March 2015, Vol 6, No 2
Read Article
CLEOPATRA: Record-Breaking Survival in HER2 Metastatic Breast Cancer by Adding Pertuzumab
Phoebe Starr
ESMO 2014 Highlights, ESMO
October 2014, Vol 5 , No 8
Read Article
Combination of BRAF and MEK Inhibitors Improves Survival in Patients with Advanced Melanoma
Phoebe Starr
ASCO 2014 Highlights, ASCO
October 2014, Vol 5 , No 8
Read Article
PD-1–Blocking Nivolumab Shows Impressive Responses in Melanoma
Phoebe Starr
ESMO 2014 Highlights, ESMO
October 2014, Vol 5 , No 8
Read Article
Record-Breaking Survival in HER2 Metastatic Breast Cancer by Adding Pertuzumab - Dual HER2 blockade a new standard of care
Phoebe Starr
ESMO 2014 Highlights, ESMO
October 2014, Vol 5 , No 8
Read Article
ALTTO: Dual Anti-HER2 Adjuvant Therapy No Better than Trastuzumab Alone
Phoebe Starr
Breast Cancer, Personalized Medicine, Value-Based Care
August 2014, Vol 5, No 6
Read Article
Cetuximab versus Bevacizumab: Comparable Benefit as First-Line Therapy for Metastatic Colorectal Cancer
Phoebe Starr
ASCO 2014 Highlights, ASCO
June 2014, Vol 5, No 5
Read Article
AZD9291, a Novel Mutation-Selective EGFR Inhibitor, May Overcome EGFR-TKI Resistance
Phoebe Starr
ASCO 2014 Highlights, ASCO
June 2014, Vol 5, No 5
Read Article
Obesity Ups Death Risk in Premenopausal Patients with ER-Positive, but Not ER-Negative, Breast Cancer
Phoebe Starr
ASCO 2014 Highlights, ASCO
June 2014, Vol 5, No 5
Read Article
Nationwide Adoption of LDCT Screening Will Detect More Early-Stage Lung Cancer, but at Substantial Economic Cost
Phoebe Starr
ASCO 2014 Highlights, ASCO
June 2014, Vol 5, No 5
Read Article
FGFR Inhibitor Shows Promising Anticancer Activity
Phoebe Starr
AACR Annual Meeting
May 2014, Vol 5, No 4
Read Article
Simple Blood Test Predicts Response to Enzalutamide in Patients with Prostate Cancer
Phoebe Starr
Personalized Medicine
May 2014, Vol 5, No 4
Read Article
PD-L1 Expression Potential Biomarker for Response to Immunotherapy with MK-3475
Phoebe Starr
Personalized Medicine
May 2014, Vol 5, No 4
Read Article
Potential New Approach to Melanoma
Phoebe Starr
AACR Annual Meeting
May 2014, Vol 5, No 4
Read Article
AG-221 Achieved Excellent Responses in Relapsed, Refractory Leukemia, Myelodysplastic Syndrome
Phoebe Starr
AACR Annual Meeting
May 2014, Vol 5, No 4
Read Article
Phi Index Can Select Patients with Prostate Cancer for Active Surveillance
Phoebe Starr
Personalized Medicine, Prostate Cancer, Solid Tumors
April 2014, Vol 5, No 3
Read Article
Encouraging Long-Term Safety Data for Radium-223
Phoebe Starr
Personalized Medicine, Prostate Cancer, Solid Tumors
March 2014, Vol 5, No 2
Read Article
Promising New Therapies in the Breast Cancer Pipeline
Phoebe Starr
Value-Based Care, VBCC Perspectives
March 2014, Vol 5, No 2
Read Article
1 in 5 US Clinical Trials Fails to Complete
Phoebe Starr
Genitourinary Cancers Symposium
February 2014, Vol 5, No 1
Read Article
Adding Radiation to Antiandrogen Hormone Therapy Extends Survival in Patients with High-Risk Prostate Cancer
Phoebe Starr
Genitourinary Cancers Symposium
February 2014, Vol 5, No 1
Read Article
Angiotensin System Inhibitors Extend Survival in Patients with Metastatic Renal-Cell Carcinoma
Phoebe Starr
Genitourinary Cancers Symposium
February 2014, Vol 5, No 1
Read Article
Adjuvant Bisphosphonates: Winner in Postmenopausal Breast Cancer
Phoebe Starr
SABCS 2014
February 2014, Vol 5, No 1
Read Article
Anastrozole Cuts the Incidence of Breast Cancer by 50% in High-Risk Women
Phoebe Starr
SABCS 2014
February 2014, Vol 5, No 1
Read Article
Enzalutamide Extends Survival in Previously Untreated Metastatic Prostate Cancer
Phoebe Starr
Genitourinary Cancers Symposium
February 2014, Vol 5, No 1
Read Article
Novel CAR-T Therapy Shows Impressive Results in Aggressive Leukemia, Lymphoma
Phoebe Starr
Leukemia, Lymphoma, Personalized Medicine
February 2014, Vol 5, No 1
Read Article
Idelalisib and Ibrutinib 2 Promising B-Cell Receptor–Signaling Inhibitors for B-Cell Malignancies
Phoebe Starr
Emerging Therapies, Personalized Medicine
October 2013, Vol 4, No 8
Read Article
Genomics of Acute Myeloid Leukemia Explored
Phoebe Starr
Personalized Medicine
October 2013, Vol 4, No 8
Read Article
Role of Radiation and Imaging in DCIS Explained
Phoebe Starr
Breast Cancer, Breast Cancer Symposium, Solid Tumors
October 2013, Vol 4, No 8
Read Article
Second-Generation ALK Inhibitor Regresses Brain Metastases in Patients with Lung Cancer
Phoebe Starr
ESMO 2013 Conference, ESMO
October 2013, Vol 4, No 8
Read Article
Kadcyla Prolongs Survival in Advanced HER2-Positive Breast Cancer
Phoebe Starr
ESMO 2013 Conference, ESMO
October 2013, Vol 4, No 8
Read Article
MPDL3280A: Responses Better in Smokers than in Nonsmokers in Advanced Lung Cancer
Phoebe Starr
ESMO 2013 Conference, ESMO
October 2013, Vol 4, No 8
Read Article
Two Genetic Tests Can Prevent Overtreatment of Early Prostate Cancer
Phoebe Starr
Personalized Medicine, Prostate Cancer
July 2013, Vol 4, No 6
Read Article
Pazopanib: First Positive Maintenance Trial in Ovarian Cancer
Phoebe Starr
ASCO Annual Meeting, ASCO
June 2013, Vol 4, No 5
Read Article
Higher HER2 Expression Leads to Better Outcomes with T-DM1 in Patients with Metastatic Breast Cancer
Phoebe Starr
Breast Cancer, Personalized Medicine, Solid Tumors
May 2013, Vol 4, No 4
Read Article
Novel Immunotherapy Approach Encouraging in Advanced Ovarian Cancer
Phoebe Starr
Ovarian Cancer, Solid Tumors
May 2013, Vol 4, No 4
Read Article
AACR Issues New Policy on Tobacco Use
Phoebe Starr
AACR Annual Meeting
May 2013, Vol 4, No 4
Read Article
Real-World Evidence Shows Impact of Musculoskeletal Toxicity of Aromatase Inhibitors on Women with Breast Cancer
Phoebe Starr
Breast Cancer, Personalized Medicine, Solid Tumors
February 2013, Vol 4, No 2
Read Article
Women with Triple-Negative Breast Cancer Very Likely to Carry BRCA1 Gene
Phoebe Starr
Personalized Medicine
February 2013, Vol 4, No 2
Read Article
A New Multigene Score Identifies Women with ER-Positive Breast Cancer at Risk for Late Metastases
Phoebe Starr
Personalized Medicine
February 2013, Vol 4, No 2
Read Article
Molecular Assays Reclassify Early Breast Cancer Type
Phoebe Starr
Breast Cancer, Personalized Medicine
February 2013, Vol 4, No 2
Read Article
Black Women with Invasive Node-Negative Breast Cancer Less Likely to Get Sentinel Lymph Node Biopsy for Axillary Staging, More Likely to Have Lymphedema
Phoebe Starr
Breast Cancer
January 2013, Vol 4, No 1
Read Article
Platinum-Resistant Ovarian Cancer: Bevacizumab Improves Survival When Added to Chemotherapy
Phoebe Starr
ESMO 2012 Conference, ESMO
November 2012, Vol 3, No 8
Read Article
Newer, More Costly Radiation Technologies Adopted in Elderly Patients with Breast Cancer
Phoebe Starr
ASTRO Annual Meeting
November 2012, Vol 3, No 8
Read Article
Proton Beam Therapy: Similar Toxicity to Standard Radiation, at Much Higher Cost
Phoebe Starr
ASTRO Annual Meeting
November 2012, Vol 3, No 8
Read Article
Stereotactic Body Radiation Therapy Cost-Saving, Convenient for Patients with Prostate Cancer
Phoebe Starr
ASTRO Annual Meeting
November 2012, Vol 3, No 8
Read Article
New Drugs for the Treatment of Prostate Cancer
Phoebe Starr
ESMO 2012 Conference, ESMO
October 2012, Vol 3, No 7
Read Article
Updated Data Confirm Survival Benefits with T-DM1 in Breast Cancer and with Regorafenib in Colon Cancer
Phoebe Starr
ESMO 2012 Conference, ESMO
October 2012, Vol 3, No 7
Read Article
Economics Impede Growth of Supportive Care Services
Phoebe Starr
Economics & Value, Economics of Cancer Care, MASCC Symposium
September 2012, Vol 3, No 6
Read Article
Biomarker Identifies Patients with Rare Brain Tumors Who Have a Survival Benefit from Chemotherapy Plus Radiation
Phoebe Starr
ASCO Annual Meeting, ASCO
June 2012, Vol 3, No 4
Read Article
Nonpharmacologic Strategies Have Mixed Results in Prostate Cancer Prevention
Phoebe Starr
Genitourinary Cancers Symposium
March 2012, Vol 3, No 2
Read Article
Long-Term Survivors of Hematopoietic Stem-Cell Transplant Pose Significant Burden to Healthcare System
Phoebe Starr
ASH Highlights, ASH 2011 Annual Meeting
March 2012, Vol 3, No 2
Read Article
Which Patients with Prostate Cancer Should Receive Hormone Therapy in Addition to Radiation?
Phoebe Starr
Personalized Medicine, Prostate Cancer, Solid Tumors
February 2012, Vol 3, No 1
Read Article
Array of Treatments for Metastatic Prostate Cancer, but Can We Afford Them?
Phoebe Starr
Genitourinary Cancers Symposium
February 2012, Vol 3, No 1
Read Article
“Pediatric-Inspired” Regimens Improve Outcomes in Adults with ALL
Phoebe Starr
NCCN Conference
December 2011, Vol 2, No 7
Read Article
Hypofractionated Radiotherapy in Prostate Cancer More Convenient for Patients
Phoebe Starr
ASTRO Annual Meeting
December 2011, Vol 2, No 7
Read Article
High-Dose Radiation Does Not Improve Survival in Stage III NSCLC
Phoebe Starr
ASTRO Annual Meeting
December 2011, Vol 2, No 7
Read Article
Reporting Gap for Near-Misses and Errors in Radiation Oncology Is Rampant
Phoebe Starr
ASTRO Annual Meeting
December 2011, Vol 2, No 7
Read Article
Role of Adjuvant Zoledronic Acid in Endocrine Receptor-Positive Breast Cancer Being Refined
Phoebe Starr
CTRC-AACR SABCS Annual Meeting
December 2011, Vol 2, No 7
Read Article
Progress in Molecular Markers that Predict Prognosis in AML
Phoebe Starr
NCCN Hematology Congress
October 2011, Vol 2, No 6
Read Article
Advances in the Management of Chronic Lymphocytic Leukemia
Phoebe Starr
NCCN Hematology Congress
October 2011, Vol 2, No 6
Read Article
Treatment Delay Feasible in Asymptomatic Follicular Lymphoma
Phoebe Starr
NCCN Hematology Congress
October 2011, Vol 2, No 6
Read Article
Novel Agents Improve Outcomes as Maintenance Therapy for Multiple Myeloma
Phoebe Starr
NCCN Hematology Congress
October 2011, Vol 2, No 6
Read Article

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

Stay In The Know

Stay up to date on the matters of value in cancer by signing up for the free, bi-monthly VBCC print publication and VBCC weekly e‑newsletter.

Subscribe
© Amplity Health. All Rights Reserved. Privacy Policy.